Ghent University Academic Bibliography

Journal Article
A1
open access

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP) : a multicountry, randomised, open-label, non-inferiority trial

Georg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, Andrea Antinori, Rafael Micán, Francesco G Genderini, Frank A Post, Jürgen K Rockstroh, Lisa Hamzah, Pere Domingo, et al.

(2026) LANCET INFECTIOUS DISEASES. 26(5). p.510-521

Add to list

Journal Article
A1
open access

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC) : a randomised controlled trial

Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, Najib M Rahman, Duncan B Richards, Gail Hayward, Jienchi Dorward, David M Lowe, Joseph F Standing, Judith Breuer, et al.

(2025) LANCET INFECTIOUS DISEASES. 25(1). p.68-79

Add to list

Miscellaneous

Europe needs a sustainably funded influenza research and response network

Florian Krammer, Wendy S Barclay, Martin Beer, Ian H Brown, Rebecca Jane Cox, Menno D de Jong, Ervin Fodor, Ron A M Fouchier, Gülsah Gabriel, Adolfo García-Sastre, et al.

(2025) LANCET INFECTIOUS DISEASES. 25(4). p.369-372

Add to list

A reference standard for urinary tract infection research : a multidisciplinary Delphi consensus study

Manu P Bilsen, Simon P Conroy, Caroline Schneeberger, Tamara N Platteel, Cees van Nieuwkoop, Lona Mody, Jeffrey M Caterino, Suzanne E Geerlings, Bela Köves, Florian Wagenlehner, et al.

(2024) LANCET INFECTIOUS DISEASES. 24(8). p.e513-e521

Add to list

Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania : a diagnostic accuracy study

Dominik Stelzle, Charles E Makasi, Veronika Schmidt, Inge Van Damme (UGent) , Chiara Trevisan (UGent) , Charlotte Ruether, Agnès Fleury, John Noh, Sukwan Handali, Pierre Dorny (UGent) , et al.

(2024) LANCET INFECTIOUS DISEASES. 24(1). p.98-106

Add to list

Journal Article
A1
open access

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

Isabel Leroux-Roels (UGent) , Chittappen Kandiyil Prajeeth, Amare Aregay, Niranjana Nair, Guus F Rimmelzwaan, Albert D M E Osterhaus, Simone Kardinahl, Sabrina Pelz, Stephan Bauer, Valentino D'Onofrio (UGent) , et al.

(2024) LANCET INFECTIOUS DISEASES. 24(11). p.1245-1253

Add to list

Miscellaneous

Antibiotic de-escalation : finally, some action and not only words

Alexis Tabah, Liesbet De Bus (UGent) and Marc Leone

(2024) LANCET INFECTIOUS DISEASES. 24(4). p.331-333

Add to list

Guideline adherence and survival of patients with candidaemia in Europe : results from the ECMM Candida III multinational European observational cohort study

Martin Hoenigl, Jon Salmanton-García, Matthias Egger, Jean-Pierre Gangneux, Tihana Bicanic, Sevtap Arikan-Akdagli, Ana Alastruey-Izquierdo, Nikolai Klimko, Aleksandra Barac, Volkan Özenci, et al.

(2023) LANCET INFECTIOUS DISEASES. 23(6). p.751-761

Add to list

Journal Article
A1
open access

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

Isabel Leroux-Roels (UGent) , Paul Willems, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Jacques Bruhwyler, Azhar Alhatemi (UGent) , Bart Jacobs (UGent) , Florence Nicolas, et al.

(2023) LANCET INFECTIOUS DISEASES. 23(12). p.1360-1369

Add to list

Multinational consensus antimicrobial stewardship recommendations for children managed in hospital settings

B McMullan, PA Bryant, E Duffy, J Bielicki, Pieter De Cock (UGent) , M Science, T Zembles, K Timberlake, E Monsees, RF Hamdy, et al.

(2023) LANCET INFECTIOUS DISEASES. 23(6). p.E199-E207

Academic Bibliography

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP) : a multicountry, randomised, open-label, non-inferiority trial

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC) : a randomised controlled trial

Europe needs a sustainably funded influenza research and response network

A reference standard for urinary tract infection research : a multidisciplinary Delphi consensus study

Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania : a diagnostic accuracy study

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

Antibiotic de-escalation : finally, some action and not only words

Guideline adherence and survival of patients with candidaemia in Europe : results from the ECMM Candida III multinational European observational cohort study

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

Multinational consensus antimicrobial stewardship recommendations for children managed in hospital settings

Contents

Support

Contact